These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 124700)

  • 61. Chromosome clues to acute leukemia in Down's syndrome.
    Hecht F; Hecht BK; Morgan R; Sandberg AA; Link MP
    Cancer Genet Cytogenet; 1986 Mar; 21(2):93-8. PubMed ID: 2936445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Second-trimester cancer antigen 125 and Down's syndrome.
    Van Blerk M; Smitz J; De Catte L; Kumps C; Van der Elst J; Van Steirteghem AC
    Prenat Diagn; 1992 Dec; 12(12):1062-6. PubMed ID: 1287642
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunological and virological investigations in Down's syndrome.
    Fekete G; Kulcsár G; Dán P; Nász I; Schuler D; Dobos M
    Eur J Pediatr; 1982 Feb; 138(1):59-62. PubMed ID: 6281021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adults with Down's syndrome: the prevalence of complications and health care in the community.
    Henderson A; Lynch SA; Wilkinson S; Hunter M
    Br J Gen Pract; 2007 Jan; 57(534):50-5. PubMed ID: 17244425
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Observations on the levels of gamma G, gamma A, gamma M globulins, anti-A and anti-B agglutinins, and antibodies to Escherichia coli in Down's anomaly.
    Adinolfi M; Gardner B; Martin W
    J Clin Pathol; 1967 Nov; 20(6):860-4. PubMed ID: 4177796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-mediated immune response in patients with Down's syndrome.
    Szigeti R; Révész T; Schuler D
    Acta Paediatr Acad Sci Hung; 1974; 15(1):31-9. PubMed ID: 4277396
    [No Abstract]   [Full Text] [Related]  

  • 68. [Australia antigen in children with Down's syndrome].
    Korczowski R
    Pol Tyg Lek; 1972 Feb; 27(9):327-9. PubMed ID: 4259782
    [No Abstract]   [Full Text] [Related]  

  • 69. [Australia antigen in patients with Down's syndrome].
    Zdzienicka E; Kacperska E
    Neurol Neurochir Pol; 1973; 7(6):765-9. PubMed ID: 4272130
    [No Abstract]   [Full Text] [Related]  

  • 70. HL-A antigens in a Chinese population.
    Hsia S; Ward FE; Chen WY; Amos DB
    Tissue Antigens; 1975 Jul; 6(1):15-22. PubMed ID: 50647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The sequence of eruption of the permanent dentition in a Chilean sample with Down's syndrome.
    Jara L; Ondarza A; Blanco R; Valenzuela C
    Arch Oral Biol; 1993 Jan; 38(1):85-9. PubMed ID: 8442726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased frequency of HL-A8 in Sjogren's syndrome.
    Gershwin ME; Terasaki I; Graw R; Chused TM
    Tissue Antigens; 1975 Nov; 6(5):342-6. PubMed ID: 1216249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
    Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
    Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The HL-A system and its clinical significance].
    Schneider W; Brunner B
    Pharm Unserer Zeit; 1975 Jan; 4(1):11-6. PubMed ID: 1144474
    [No Abstract]   [Full Text] [Related]  

  • 75. Down's syndrome in Hyderabad, India.
    Isaac GS; Krishnamurty PS; Reddy YR; Ahuja YR
    Acta Anthropogenet; 1985; 9(4):256-60. PubMed ID: 2967078
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defective monocyte chemotaxis in children with Down's syndrome.
    Barroeta O; Nungaray L; López-Osuna M; Armendares S; Salamanca F; Kretschmer RR
    Pediatr Res; 1983 Apr; 17(4):292-5. PubMed ID: 6222283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparative coherence studies in healthy volunteers and Down's syndrome patients from childhood to adult age.
    Schmid RG; Tirsch WS; Rappelsberger P; Weinmann HM; Pöppl SJ
    Electroencephalogr Clin Neurophysiol; 1992 Aug; 83(2):112-23. PubMed ID: 1378376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.